'Sputnik V' vaccines arrive in India, clinical trials shortly

New Delhi: Russia’s coronavirus vaccine, 'Sputnik V' has reportedly arrived in India after Dr Reddy’s Laboratories got approval to conduct an adaptive phase 2/3 human clinical trial of the vaccine.

A video surfaced on social media, which shows containers with logos of Sputnik V and Dr Reddy's being unloaded from a small truck. A senior official from Dr Reddy's, confirmed the arrival of the vaccine in India, and added that the trials will commence soon.

The development comes at a time when Russia's Gamaleya National Research Institute of Epidemiology and Microbiology claimed that Sputnik V demonstrated an efficacy rate of 92 per cent.

In September 2020, Dr. Reddys and Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.



Asianet.in/NewsDesk: Asianet Online